Norway - Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics
With €5,653,370.5 in 2019, the country was number 28 among other countries in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics. Norway is overtaken by Slovenia, which was number 27 at €29,086,871.67 and is followed by Montenegro at €3,782,118. Germany topped the ranking with €16,376,860,638.2 in 2019, an increase of 0.5% versus 2018. Ireland, France and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Sweden recorded the best 5 years average growth at +62.7% per year, while Montenegro witnessed the worst performance at -6.3% per year.
Loading...
Date | Euros |
---|---|
2019 | 5,653,370.50 |
2018 | 0.00 |
2017 | 35,008,363.00 |
2016 | 40,592,319.00 |
2015 | 13,254,000.00 |
Download all data from 1998 to 2019
How does Norway rank in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics?
# | 29 Countries | Euros | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Germany
|
16,376,860,638.20 | 2019 | +0.5 % | +3.5 % | View data | |
2 |
#2
Ireland
|
14,139,386,320.45 | 2019 | +21.9 % | -5.8 % | View data | |
27 |
#27
Slovenia
|
29,086,871.67 | 2019 | -26.5 % | NA | View data | |
28 |
#28
Norway
|
5,653,370.50 | 2019 | NA | NA | View data | |
29 |
#29
Montenegro
|
3,782,118.00 | 2019 | -4.5 % | -6.3 % | View data |